rs2568958 — NEGR1 NEGR1 depression/BMI variant
Intergenic tag SNP near NEGR1 associated with elevated BMI and major depression risk through hypothalamic NEGR1 expression — one of the most replicated obesity GWAS loci and a genome-wide significant depression locus
Details
- Gene
- NEGR1
- Chromosome
- 1
- Risk allele
- G
- Clinical
- Risk Factor
- Evidence
- Strong
Population Frequency
Category
Mood & BehaviorSee your personal result for NEGR1
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
NEGR1 and the Mood-Weight Connection — When Your Brain's Wiring Governs Both
Most genetic risk factors influence one thing. NEGR111 NEGR1
Neuronal Growth Regulator 1 —
a GPI-anchored cell adhesion molecule in the IgLON superfamily, expressed on the surface
of neurons in the hypothalamus, hippocampus, and prefrontal cortex. GPI-anchored means
the protein is tethered to the outer cell membrane by a lipid anchor rather than spanning
it — placing NEGR1 at the neuron's outermost face where it mediates cell-to-cell contact
influences two. Variants near this gene are among the most replicated findings in both
the obesity and the major depression genetics literature — the same neurons that control
appetite circuits in the hypothalamus also organize the monoaminergic signaling that
underlies mood regulation.
Rs2568958 sits near a 45-kilobase deletion polymorphism upstream of NEGR1 that was first
identified in 2009 as one of six new BMI loci22 six new BMI loci
Willer CJ et al. Six new loci associated
with body mass index highlight a neuronal influence on body weight regulation.
Nat Genet, 2009 reaching genome-wide significance,
and has since been independently confirmed in the depression GWAS literature as part of the
same causal signal.
The Mechanism
NEGR1 belongs to the IgLON superfamily33 IgLON superfamily
A family of immunoglobulin-domain cell adhesion
molecules — LSAMP, OPCML, NRCAM, NEGR1, and HNT/NTROPHY — that guide axonal growth and
synapse formation. They are expressed on the outer surface of neurons and regulate which
neurons bond with which, effectively controlling the wiring diagram of the developing and
adult brain. In the hypothalamus, NEGR1 guides the physical architecture of circuits
that integrate energy status signals with behavioral outputs — it helps wire the neurons
that receive leptin and insulin signals and translate them into satiety, mood, and energy
expenditure.
The rs2568958 G allele disrupts NEGR1 expression through two mechanisms. First, it lies
near a structural deletion44 structural deletion
The Willer 2009 study identified a 45-kb deletion immediately
upstream of NEGR1, perfectly tagged by the lead SNPs in this region (including rs2815752
and rs2568958). Deletion of this segment removes regulatory sequences that drive NEGR1
expression, particularly in hypothalamic neurons in the NEGR1 upstream region that
removes regulatory sequences controlling hypothalamic expression. Second, eQTL analyses
in the Levey et al. 202155 Levey et al. 2021
Levey DF et al. Bi-ancestral depression GWAS in the Million
Veteran Program and meta-analysis in >1.2 million individuals. Nat Neurosci,
2021 dataset confirmed that the depression-risk
allele at the NEGR1 locus acts as a brain eQTL: it statistically predicts lower NEGR1
mRNA abundance specifically in hypothalamic tissue. Less NEGR1 protein means less
synaptic scaffolding in exactly the circuits that connect mood and appetite.
In animal models, NEGR1-deficient mice66 NEGR1-deficient mice
Noh K et al. Negr1 controls adult hippocampal
neurogenesis and affective behaviors. Mol Psychiatry,
2019 show severely impaired long-term
potentiation in the hippocampal dentate gyrus, near-abolition of adult neurogenesis, and
robust depression- and anxiety-like behaviors across validated assays. The mechanistic
pathway proceeds through the LIFR–Lcn2 axis: NEGR1 activates the leukemia inhibitory
factor receptor, which drives Lipocalin-2 production, which is itself required for
hippocampal neurogenesis. Meanwhile, a 2022 study by Kaare et al.77 Kaare et al.
Kaare M et al.
Depression-Associated Negr1 Gene-Deficiency Induces Alterations in the Monoaminergic
Neurotransmission. Brain Sciences, 2022
found dysregulated signaling across all three monoamine systems — elevated striatal dopamine
release, altered hippocampal serotonin, and disrupted norepinephrine responses — confirming
that NEGR1's role extends well beyond structural wiring into active neurotransmitter circuit
organization.
The Evidence
The BMI evidence arrived first. In the landmark Willer et al. 200988 Willer et al. 2009
Willer CJ et al.
Six new loci associated with body mass index. Nat Genet,
2009 meta-analysis of over 32,000 individuals,
the NEGR1 locus reached genome-wide significance for BMI with an effect of approximately
0.05 SD units per allele (~0.36 kg/m²). Crucially, several of the identified loci —
including NEGR1 — were expressed in the central nervous system, pointing to a neuronal
rather than peripheral mechanism for their effect on body weight.
The depression evidence followed years later at far greater statistical power. The
Howard et al. 201999 Howard et al. 2019
Howard DM et al. Genome-wide meta-analysis of depression identifies
102 independent variants. Nat Neurosci,
2019 study (N=807,553, including 246,363
cases) identified the NEGR1 locus at P=3.55×10⁻¹⁵ for major depression. This finding
was further strengthened in the Levey et al. 20211010 Levey et al. 2021
Levey DF et al. Bi-ancestral
depression GWAS. Nat Neurosci, 2021 analysis
(N=1,154,267) where the lead NEGR1 SNP reached P=8.9×10⁻²⁹ — one of the highest-confidence
depression loci in the human genome.
The shared genetic signal was formally characterized by Zhang et al. 20241111 Zhang et al. 2024
Zhang H et al.
Dissecting shared genetic architecture between depression and body mass index. BMC Medicine,
2024: depression and BMI share a genetic
correlation of rg=0.19 (P=4×10⁻²⁶), and among all shared loci, NEGR1 was the single most
significant gene. Brain tissue from individuals with both depression and obesity showed the
greatest reductions in NEGR1 expression, concentrated in the nucleus accumbens and anterior
cingulate cortex — reward and emotional valuation centers.
Replication of rs2568958 specifically extends to African-American populations: Hester et al.
20111212 Hester et al.
2011
Hester JM et al. Implication of European-derived adiposity loci in African Americans.
PLoS Genet, 2011 confirmed the rs2568958-BMI
association (P<0.05) across six African-American cohorts (N=4,992), with effect sizes of
0.04–0.06 SD units per allele — demonstrating this is not a European-specific finding.
Practical Implications
For G-allele carriers, the actionable insight sits at the intersection of the two pathways NEGR1 organizes: hippocampal neurogenesis and hypothalamic monoamine architecture. Aerobic exercise is the most potent behavioral driver of BDNF-mediated hippocampal neurogenesis — directly compensating for reduced LIFR-Lcn2 signaling. Dietary protein provides the precursors (tryptophan for serotonin, tyrosine for dopamine/norepinephrine) that feed the monoamine circuits disorganized by NEGR1 reduction. Omega-3 EPA/DHA supports neuronal membrane fluidity and monoamine receptor function. The dual mood-metabolic nature of NEGR1 means interventions supporting one pathway tend to benefit both.
Interactions
Rs2568958 is one of several SNPs tagging the same NEGR1 risk locus — rs34579341, rs2815752, rs11209948, and rs7531118 are all in moderate-to-high linkage disequilibrium with it. Users who have results for rs34579341 are reading from the same causal signal. The depression signal at NEGR1 interacts with BDNF Val66Met (rs6265): since NEGR1 drives hippocampal neurogenesis through the LIFR-Lcn2 axis that converges on BDNF, carriers of both G at rs2568958 and Met at rs6265 face compounded neurogenic impairment. COMT (rs4680) represents a relevant monoaminergic interaction given the dopamine and norepinephrine dysregulation documented in NEGR1-deficient animals.
Genotype Interpretations
What each possible genotype means for this variant:
Common NEGR1 variant — standard hypothalamic circuit architecture
At rs2568958, the A allele (~67.5% globally) represents the population-normal state for NEGR1 upstream regulatory sequences. The GRCh38 reference genome carries the minor G allele at this position, but genomic databases and GWAS literature consistently identify A as the common, non-risk allele. AA homozygotes show normal NEGR1 expression in hypothalamic eQTL analyses and do not carry the depression or BMI risk conferred by the G allele at this locus. Other loci — including additional NEGR1 variants, BDNF rs6265, COMT rs4680, and HTR2A rs6311 — may independently influence mood and weight through different mechanisms.
One copy of the NEGR1 risk allele — mildly reduced hypothalamic NEGR1 expression
The AG genotype at rs2568958 carries one copy of the G allele, which tags a structural deletion upstream of NEGR1 that reduces its expression in the hypothalamus. The depression GWAS literature (Howard 2019, Levey 2021) uses an additive model across the NEGR1 locus, meaning each G allele incrementally reduces NEGR1 expression and incrementally increases risk. Effect sizes per allele in BMI studies average ~0.05 SD units (~0.36 kg/m²) — small individually but meaningful in combination with other metabolic loci.
NEGR1 expression in the hypothalamus governs the physical architecture of circuits integrating energy signals (leptin, insulin) with appetite and emotional regulation. Reduced expression through the G allele disrupts both the neurogenic LIFR-Lcn2 axis in the hippocampus and the dopamine/serotonin/norepinephrine circuit organization studied in NEGR1-deficient mouse models. For heterozygous carriers, the impairment is partial but present across both pathways.
Two copies of the NEGR1 risk allele — greatest reduction in hypothalamic NEGR1 expression
The GG homozygous state at rs2568958 represents the highest-exposure genotype for the upstream structural deletion that reduces NEGR1 expression. The NEGR1 locus depression signal reaches P=3.55×10⁻¹⁵ in Howard et al. 2019 (N=807,553) and P=8.9×10⁻²⁹ in Levey et al. 2021 (N=1,154,267). The additive model means GG carriers carry approximately double the per-allele risk shift compared to AG carriers.
Mechanistically, NEGR1-deficient animal models (Noh et al. 2019, Kaare et al. 2022) show: (1) severely impaired hippocampal long-term potentiation and near-abolition of adult dentate gyrus neurogenesis; (2) elevated striatal dopamine release; (3) altered hippocampal serotonin levels; (4) disrupted norepinephrine and normetanephrine ratios; (5) reduced hippocampal volume (rescued by escitalopram treatment). These functional data illustrate the downstream consequences of the gene expression deficit this variant tags.
The Zhang et al. 2024 analysis found that NEGR1 expression is significantly lower in brain tissues of people with both depression and obesity — with the strongest effect in the nucleus accumbens (reward) and anterior cingulate cortex (emotional evaluation). GG carriers at rs2568958 sit at the highest genetic-risk end of the NEGR1 expression continuum at this locus. Genetic risk does not determine outcome, but it identifies where proactive support is most warranted.